- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05938569
Computer-Assisted Hair Restoration Study Using ARTAS System
July 5, 2023 updated by: Venus Concept
Prospective, multi-center, up to 4 investigational centers evaluating the performance of the ARTAS System in Hair Restoration Procedures.
Study Overview
Study Type
Interventional
Enrollment (Estimated)
150
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Director of Clinical Affairs, PhD
- Phone Number: 8889070115
- Email: mgronski@venusconcept.com
Study Locations
-
-
California
-
Los Altos, California, United States, 94022
- Recruiting
- Berman Skin Institute
-
Contact:
- David Berman, M.D.
- Phone Number: 650-325-6000
- Email: david.berman@skinmds.com
-
Contact:
- Anna Marte
- Phone Number: (650) 325-6000
- Email: anna.marte@skinmds.com
-
Principal Investigator:
- David Berman, M.D.
-
San Jose, California, United States, 95112
- Recruiting
- Le's Aesthetics
-
Contact:
- Vincent Le, D.O.
- Phone Number: 408-835-9977
- Email: vle02@yahoo.com
-
Contact:
- Lin Phong
- Phone Number: 408-835-9977
- Email: infohaircenters@gmail.com
-
Principal Investigator:
- Vincent Le
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Subject is male with clinical diagnosis of androgenetic alopecia with Norwood-Hamilton grade of III-VI
- Subject is 20 to 70 years old
- Subject agrees to cut hair short (< 1 mm) on the scalp in the designated study areas for harvesting and implantation
- Subject is able to understand and provide written consent
- Subject consents to post-operative follow-up per protocol
Exclusion Criteria:
- Subject has prior history of scalp reduction surgery(s) in the past six months
- Subject has bleeding diathesis
- Subject has active use of anti-coagulation medication
- Subject has any other condition that, in the opinion of the investigator, makes the subject inappropriate to take part in this study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: All subjects
The Study Treatment will involve follicular hair unit harvest, recipient site making, and implantation.
|
The Study Treatment will involve follicular hair unit harvest, recipient site making, and implantation.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change in Hair Density from pre to 12 months post-treatment in robotic vs manual implantation
Time Frame: 1 year post-treatment
|
1 year post-treatment
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Percentage of follicles successfully harvested by Robot
Time Frame: 1 year post-treatment
|
1 year post-treatment
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 3, 2016
Primary Completion (Estimated)
December 30, 2024
Study Completion (Estimated)
December 30, 2024
Study Registration Dates
First Submitted
June 27, 2023
First Submitted That Met QC Criteria
July 5, 2023
First Posted (Actual)
July 10, 2023
Study Record Updates
Last Update Posted (Actual)
July 10, 2023
Last Update Submitted That Met QC Criteria
July 5, 2023
Last Verified
July 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CP-017
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Androgenic Alopecia
-
Galderma R&DCompletedFemale Pattern Hair Loss, Androgenic AlopeciaUnited States
-
Galderma R&DCompletedMale Pattern of Hair Loss, Androgenic AlopeciaUnited States
-
Clinica Dermatologica Arbache ltdaRecruiting
-
Kasr El Aini HospitalRecruiting
-
Beauty HealthCallender Center for Clinical Research; ATS Clinical Research; Skin Surgery Medical... and other collaboratorsCompletedAndrogenic AlopeciaUnited States
-
Restoration Robotics, Inc.UnknownAndrogenic AlopeciaUnited States
-
Mohammed Abd El Mawgoud AmerRecruiting
-
Yale UniversityCompletedAndrogenic AlopeciaUnited States
-
Jinan University GuangzhouCompleted
-
Dong-A ST Co., Ltd.CompletedAndrogenic AlopeciaKorea, Republic of
Clinical Trials on Hair restoration
-
Nutraceutical Wellness Inc.Not yet recruitingHair ThinningUnited States
-
BrandiZoneCitruslabsCompletedHair Loss | Hair HealthUnited States
-
Cairo UniversityUnknown
-
Nutraceutical Wellness Inc.Not yet recruitingHair ThinningUnited States
-
Federal University of PelotasUnknownEndodontically Treated TeethBrazil
-
Freedom Laser Therapy, Inc.TKL Research, Inc.UnknownAndrogenetic AlopeciaUnited States
-
University Hospital, ToulouseNot yet recruitingMolar Incisor HypomineralizationFrance
-
Instituto de Oncología Ángel H. RoffoRecruitingChemotherapy-induced AlopeciaArgentina
-
Gundersen Lutheran Medical FoundationGundersen Lutheran Health SystemCompletedSurgical Site Infection | Superficial Surgical Site Infection | Deep Surgical Site Infection | Organ/Space Surgical Site InfectionUnited States